Multi-omics approaches have transformed medical research by enabling the integration of diverse omics data types to understand disease mechanisms. These approaches combine genomics, transcriptomics, proteomics, metabolomics, and microbiomics to provide a comprehensive view of biological processes. This review discusses the integration of multi-omics data to identify molecular patterns associated with disease, emphasizing the importance of considering the complexity of disease etiology and the limitations of single-omics studies. Genomics focuses on identifying genetic variants associated with disease, while epigenomics examines reversible modifications of DNA and proteins. Transcriptomics analyzes RNA levels, proteomics quantifies protein abundance and modifications, and metabolomics measures small molecule levels. Microbiomics investigates microbial communities and their impact on health. These data types, when integrated, offer insights into the molecular mechanisms underlying disease and can help identify therapeutic targets. The integration of multi-omics data is crucial for understanding the complex interactions between genetic, environmental, and cellular factors in disease. Different approaches, such as genome-first, phenotype-first, and environment-first, are used to analyze these interactions. Genome-first approaches focus on identifying causal variants and their effects on gene expression, while phenotype-first approaches examine how disease-related phenotypes are influenced by various omics data. Environment-first approaches investigate how environmental factors, such as diet, affect disease mechanisms. Challenges in multi-omics studies include the complexity of data integration, the need for large sample sizes, and the influence of confounding factors. Advances in technology and statistical methods are improving the resolution and accuracy of omics data, enabling more precise identification of disease-related molecular mechanisms. Future directions include the application of multi-omics approaches to understudied populations, particularly in the context of sex-specific differences, and the development of more informative models of biological context in disease. The integration of omics data with lifestyle and environmental factors is also expected to enhance personalized treatment strategies.Multi-omics approaches have transformed medical research by enabling the integration of diverse omics data types to understand disease mechanisms. These approaches combine genomics, transcriptomics, proteomics, metabolomics, and microbiomics to provide a comprehensive view of biological processes. This review discusses the integration of multi-omics data to identify molecular patterns associated with disease, emphasizing the importance of considering the complexity of disease etiology and the limitations of single-omics studies. Genomics focuses on identifying genetic variants associated with disease, while epigenomics examines reversible modifications of DNA and proteins. Transcriptomics analyzes RNA levels, proteomics quantifies protein abundance and modifications, and metabolomics measures small molecule levels. Microbiomics investigates microbial communities and their impact on health. These data types, when integrated, offer insights into the molecular mechanisms underlying disease and can help identify therapeutic targets. The integration of multi-omics data is crucial for understanding the complex interactions between genetic, environmental, and cellular factors in disease. Different approaches, such as genome-first, phenotype-first, and environment-first, are used to analyze these interactions. Genome-first approaches focus on identifying causal variants and their effects on gene expression, while phenotype-first approaches examine how disease-related phenotypes are influenced by various omics data. Environment-first approaches investigate how environmental factors, such as diet, affect disease mechanisms. Challenges in multi-omics studies include the complexity of data integration, the need for large sample sizes, and the influence of confounding factors. Advances in technology and statistical methods are improving the resolution and accuracy of omics data, enabling more precise identification of disease-related molecular mechanisms. Future directions include the application of multi-omics approaches to understudied populations, particularly in the context of sex-specific differences, and the development of more informative models of biological context in disease. The integration of omics data with lifestyle and environmental factors is also expected to enhance personalized treatment strategies.